ArticleEuropean urology oncology2025

Genomic and Epigenomic Signatures Can Distinguish Aggressive Chromophobe Renal Cell Carcinoma from Indolent Renal Oncocytic Tumors in Clinical-grade Samples.

Roberto Ruiz-Cordero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.